AR224614A1 - Procedimiento para la elaboracion de nuevos compuestos de 2-oxo-2,3-dihidro-benzo(b)tiofeno - Google Patents

Procedimiento para la elaboracion de nuevos compuestos de 2-oxo-2,3-dihidro-benzo(b)tiofeno

Info

Publication number
AR224614A1
AR224614A1 AR271100A AR27110078A AR224614A1 AR 224614 A1 AR224614 A1 AR 224614A1 AR 271100 A AR271100 A AR 271100A AR 27110078 A AR27110078 A AR 27110078A AR 224614 A1 AR224614 A1 AR 224614A1
Authority
AR
Argentina
Prior art keywords
tiofeno
dihidro
elaboration
benzo
oxo
Prior art date
Application number
AR271100A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH453876A external-priority patent/CH630082A5/de
Priority claimed from CH1599476A external-priority patent/CH629797A5/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Application granted granted Critical
Publication of AR224614A1 publication Critical patent/AR224614A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AR271100A 1976-04-09 1978-02-14 Procedimiento para la elaboracion de nuevos compuestos de 2-oxo-2,3-dihidro-benzo(b)tiofeno AR224614A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH453876A CH630082A5 (de) 1976-04-09 1976-04-09 Verfahren zur herstellung von oxothiaverbindungen.
CH1599476A CH629797A5 (en) 1976-12-20 1976-12-20 Process for the preparation of salts of oxothia compounds

Publications (1)

Publication Number Publication Date
AR224614A1 true AR224614A1 (es) 1981-12-30

Family

ID=25695718

Family Applications (3)

Application Number Title Priority Date Filing Date
AR267166A AR218869A1 (es) 1976-04-09 1977-04-11 Procedimiento para la elaboracion de compuestos de 2-oxo-2,3-dihidro-3-benzo(b)tiofencarboxamida n-sustituida
AR271101A AR225401A1 (es) 1976-04-09 1978-02-14 Procedimiento para la elaboracion de nuevos compuestos de 2-oxo-2,3-dihidro-benzo(b)tiofeno
AR271100A AR224614A1 (es) 1976-04-09 1978-02-14 Procedimiento para la elaboracion de nuevos compuestos de 2-oxo-2,3-dihidro-benzo(b)tiofeno

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AR267166A AR218869A1 (es) 1976-04-09 1977-04-11 Procedimiento para la elaboracion de compuestos de 2-oxo-2,3-dihidro-3-benzo(b)tiofencarboxamida n-sustituida
AR271101A AR225401A1 (es) 1976-04-09 1978-02-14 Procedimiento para la elaboracion de nuevos compuestos de 2-oxo-2,3-dihidro-benzo(b)tiofeno

Country Status (27)

Country Link
US (1) US4320138A (es)
JP (1) JPS52125158A (es)
AR (3) AR218869A1 (es)
AT (1) AT357148B (es)
CA (1) CA1112248A (es)
CS (4) CS207395B2 (es)
CY (1) CY1138A (es)
DD (1) DD130659A5 (es)
DE (1) DE2713584C2 (es)
DK (1) DK152046C (es)
ES (1) ES457528A1 (es)
FI (1) FI69461C (es)
FR (1) FR2347363A1 (es)
GB (1) GB1544339A (es)
GR (1) GR70652B (es)
HK (1) HK6182A (es)
HU (1) HU180438B (es)
IE (1) IE44987B1 (es)
IL (1) IL51847A (es)
KE (1) KE3185A (es)
MY (1) MY8200244A (es)
NL (1) NL7703802A (es)
NO (1) NO146810C (es)
NZ (1) NZ183747A (es)
PL (3) PL110653B1 (es)
SE (1) SE432930B (es)
SU (4) SU795475A3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634840A5 (de) * 1978-06-29 1983-02-28 Ciba Geigy Ag 2-oxo-2,3-dihydro-benzo(b)thiophen-verbindung und daraus hergestellte pharmazeutische praeparate.
AT392787B (de) * 1978-06-29 1991-06-10 Ciba Geigy Ag Verfahren zur herstellung des neuen n-(2-thienyl)-2-oxo-2,3-dihydro-benzo(b)thiophen-3-carboxamids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413308A (en) * 1966-09-02 1968-11-26 Dow Chemical Co Substituted benzo(b)thiophene-2-carboxanilides
US3655693A (en) * 1969-06-25 1972-04-11 Merck & Co Inc Anti-inflammatory salicyclic acid derivatives
US3676463A (en) * 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3971814A (en) * 1972-11-27 1976-07-27 Warner-Lambert Company Benzo(b)thiophene derivatives
GB1571847A (en) * 1974-01-02 1980-07-23 Systems Eng & Mfg Waste water treatment

Also Published As

Publication number Publication date
HK6182A (en) 1982-02-19
CS207392B2 (en) 1981-07-31
FR2347363B1 (es) 1979-03-09
ATA248577A (de) 1979-11-15
DK152046C (da) 1988-07-18
CS207395B2 (en) 1981-07-31
HU180438B (en) 1983-03-28
NO146810C (no) 1982-12-15
PL197311A1 (pl) 1978-01-16
DK158777A (da) 1977-10-10
MY8200244A (en) 1982-12-31
NL7703802A (nl) 1977-10-11
SU795475A3 (ru) 1981-01-07
SE432930B (sv) 1984-04-30
SE7704033L (sv) 1977-10-10
KE3185A (en) 1982-04-02
PL111459B1 (en) 1980-08-30
PL111456B1 (en) 1980-08-30
SU738510A3 (ru) 1980-05-30
DK152046B (da) 1988-01-25
SU791239A3 (ru) 1980-12-23
AT357148B (de) 1980-06-25
CS207393B2 (en) 1981-07-31
NO146810B (no) 1982-09-06
SU898956A3 (ru) 1982-01-15
JPS52125158A (en) 1977-10-20
NO771231L (no) 1977-10-11
IL51847A (en) 1981-09-13
PL110653B1 (en) 1980-07-31
NZ183747A (en) 1979-01-11
FR2347363A1 (fr) 1977-11-04
GR70652B (es) 1982-12-03
DE2713584A1 (de) 1977-10-20
CY1138A (en) 1982-05-07
IE44987L (en) 1977-10-09
FI771044A (es) 1977-10-10
FI69461C (fi) 1986-02-10
IE44987B1 (en) 1982-06-02
US4320138A (en) 1982-03-16
IL51847A0 (en) 1977-06-30
ES457528A1 (es) 1978-08-16
AR225401A1 (es) 1982-03-31
AR218869A1 (es) 1980-07-15
DD130659A5 (de) 1978-04-19
FI69461B (fi) 1985-10-31
CS207394B2 (en) 1981-07-31
DE2713584C2 (de) 1986-09-04
JPS6218556B2 (es) 1987-04-23
CA1112248A (en) 1981-11-10
GB1544339A (en) 1979-04-19

Similar Documents

Publication Publication Date Title
ES514585A0 (es) Procedimiento para la obtencion de derivados de oxazol trisustituidos.
AR220216A1 (es) Procedimiento para la preparacion de 1-(2-hidroxi-3-amino-propil sustituido)-2-nitroimidazoles
ES520089A0 (es) Procedimiento para la fabricacion de nuevos derivados arilicos de la piperacina.
MX5934E (es) Procedimiento para la preparacion de 1-substituido-4,5-diaril-2-(tiosubstituido)imidazoles
MX147703A (es) Procedimiento para la obtencion de compuestos de polifluoroaliloxi
AR221851A1 (es) Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina
AR224381A1 (es) Procedimiento para la elaboracion de 1,3-diazaciclopent-2-eno(2,1-b)(1-tia-3-aza-cicloalcanos)
IT7827903A0 (it) Procedimento per la produzione dicomposti eterociclici.
ES479490A0 (es) Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
AR227527A1 (es) Procedimiento para la elaboracion de nuevos compuestos n-oxaciclilalquil-piperidil-diazoicos
ES498210A0 (es) Procedimiento para la obtencion de derivados de 4h-3, 1 ben-zoxazina
AR225666A1 (es) Procedimiento para la produccion de derivados para la produccion de derivados de 1-alquil-1-alquenil,alcoxi o alquil-3-5-alquil,fenil o halo-3-isoxazolilourea
ES456483A0 (es) Procedimiento para la preparacion de compuestos de estilbeno.
ES493650A0 (es) Procedimiento para la fabricacion de 2(3,4,5-trimetoxifenil)tiazoles,4,5-disubstituidos
AR217806A1 (es) Procedimiento para la elaboracion de nuevas 10-halogeno-5h-dibenz(b,f)azepin-5-carboxamidas
AR225889A1 (es) Procedimiento para la elaboracion de acidos heterociclilcarboxilicos acilados
AR220120A1 (es) Procedimiento para la fabricacion de derivados de 1-alquil-4-(n-acetil)amino-tetrahidro-1,3,5-triazol-2,6-diona
AR223319A1 (es) Procedimiento para la elaboracion de compuestos de 6-amino-penam
AR225415A1 (es) Procedimiento para la obtencion de nuevos derivados de pirido(2,1-b)quinazolina
ES519477A0 (es) Procedimiento para la obtencion de derivados de n-(benzotiofenmetil)-n-metil-het-2-en-4-in-amina.
ES513169A0 (es) Procedimiento para la obtencion de nuevos derivados de benzazol.
AR216660A1 (es) Procedimiento para la obtencion de compuestos de fenilaminometilimidazolina
AR230835A1 (es) Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido
AR224614A1 (es) Procedimiento para la elaboracion de nuevos compuestos de 2-oxo-2,3-dihidro-benzo(b)tiofeno
ES493649A0 (es) Procedimiento para la fabricacion de 4-tiazolidonas,2-subs- tituidas